Andrew D.C. LaFrence
Analyst
Thank you, Jay. In the next few minutes, I will provide certain details of our financial performance in the second quarter of 2025. I would encourage you to review our Form 8-K containing our press release and non-GAAP measures as well as our quarterly report on Form 10-Q filed earlier this morning with the U.S. Securities and Exchange Commission. As a continued theme, we have historically noted, our individual quarterly performance can be affected by outside factors. These might include timing fluctuations, including seasonal fluctuations, customer shipments and supply chain issues. Any of these could materially impact a particular quarter either positively or negatively. Consequently, we believe it's more important to review our business on a 12-month basis rather than focusing on quarterly performance. This approach will help normalize these potential anomalies and offer a better gauge of our strategy's long-term success. So today, while I'll focus most of my comments on our second quarter results, I will spend some time reviewing trailing 12 months results for the business. Net sales for the second quarter of 2025 totaled $30.7 million. This represents a 9.5% decrease from the net sales of $33.9 million in the second quarter of 2024. Net sales in the second quarter of 2025 were negatively impacted by delays in aerospace and defense customers' approvals of products transferred from our Blue Earth facility to our Bemidji facility as well as manufacturing and plant utilization inefficiencies related to the movement of various production between plants. As Jay noted, we made significant headway with the transfer of these customer programs in the first half of 2025. Our customer backlog at the end of the second quarter of 2025 grew approximately $10 million from March 31, 2025, to $78.4 million. Second quarter 2025 gross profit totaled $4.8 million or 15.8% of net sales compared with gross profit of $4.6 million or 13.6% of net sales in the same prior year quarter. The increase in gross profit as a percentage of net sales in the current year period was a result of increased facility utilization and increased manufacturing productivity, which was more than offset by lower net sales. Operating expenses for the second quarter were down $178,000 as compared with the prior year period as a result of higher selling expenses from the realignment of our customer-facing managers to a sales function reporting to business development that were previously included in cost of sales. This increase is more than offset by lower payroll costs and expense management as well as reduced restructuring costs. We completed the sale of our Blue Earth facility in July, which further reduces our ongoing operating expenses. Moving to the cash flow statement. For the 6 months ended June 30, 2025, net cash used in operating activities totaled $2.8 million as compared with $1.5 million in the same period in 2024. The timing of revenue shipments as well as customer and vendor payments impacted operating cash flow for the periods. Further, we generated cash from the execution of our strategy to decrease inventory levels in the second quarter, and we plan to further reduce our investment in inventory during the remainder of 2025. As noted in our press release distributed this morning, we use earnings before interest, tax, depreciation and amortization or EBITDA as well as adjusted EBITDA, which does not reflect the restructuring charges we incurred through the second quarter related to our staff reductions and Blue Earth plant closures as key performance indicators to manage our business. While plant closure -- while EBITDA and adjusted EBITDA are non-GAAP measures, we believe these provide meaningful information regarding our underlying core business financial performance. In our press release, we have provided a reconciliation of our financial performance determined in accordance with U.S. generally accepted accounting principles and EBITDA as well as adjusted EBITDA. For the quarter ended June 30, 2025, adjusted EBITDA was $1.1 million as compared with $0.9 million in the same period in 2024. Turning to the balance sheet. As of June 30, 2025, cash totaled $652,000, down from $916,000 as of December 31, 2024. The fluctuation in cash balances reflects the timing of cash receipts, expenditures, distributions of earnings from our Chinese operations and credit line borrowings, which aggregated $11.6 million as of the end of the quarter. Accounts receivable as of June 30 were $17.8 million, up from $14.9 million as of December 31, 2024. Inventories were $18.6 million as of June 30, 2025, as compared with $21.6 million as of December 31, 2024. Our contract asset, which represents revenue earned but not yet billed to customers increased to $15 million as of June 30, 2025, as compared with $13.8 million at the end of December 2024. This increase reflects the timing of customer shipments and our focus on increased production to reduce raw material balances and optimize planned operations. In our press release issued earlier today, we presented non-GAAP results, including trailing 12-month financial data and EBITDA. For the 12 months ended June 30, 2025, net sales were $117.6 million as compared with $137.5 million for the 12-month period ended June 30, 2024. In addition, adjusted EBITDA for the 12-month period ended June 30, 2025, was negative $0.4 million as compared with $7.3 million in the 12-month period ended June 30, 2024. As we noted, over the past year, we have experienced revenue and resulting earnings headwinds from changes in customer ordering patterns, knuckle device customers post COVID rebalancing inventory levels and delays in aerospace and defense programs from being moved from Blue Earth to Bemidji. We believe that our second quarter 2020 performance and recent improved customer backlog as compared with the end of 2024 are leading indicators of tailwinds in our future revenues. Our top financial priorities for 2025 remain unchanged. First, we are extremely focused on continuing to strengthen our balance sheet, including our plan to further reduce our inventory investments in 2025. Next, we will focus on driving efficiencies in our manufacturing process, especially for those programs we have transferred over the past year to new facilities to deliver sustainable long-term EBITDA growth as well as driving improvements in free cash flow. Coupled with disciplined lean operation execution, expense management and R&D innovation, we believe Nortech can deliver on our objectives. With that, I'll now turn it back over for Jay for his closing comments. Jay?